News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target
Cybin Inc.
Diamond Therapeutics Hires Industry Veteran David Brown, PhD, to Further Advance Formulation of Psilocybin
Diamond Therapeutics
Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor
Tryp Therapeutics
Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1
Psyched Wellness
Core One Labs’ Akome Seeks to Revolutionize Treatment of Parkinson’s Disease and Submits Application to Protect IP
Core One Labs Inc.
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol "FTRP"
Field Trip Health
Joel Raskin, CMO | MINDCURE
MINDCURE
Ketamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured Veterans
Wellbeing Digital Sciences
BetterLife-Carleton University Research Team Secure Mitacs Accelerate Funding to Study the Therapeutic Effect of TD-010 in Chronic Anxiety
BetterLife Pharma
Psyched Wellness Successfully Completes Its Largest Extraction and Shipment of AME-1 to Asia
Psyched Wellness
Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds
Mydecine Innovations Group
Red Light Holland Files New Patent: Technology and Devices for Monitoring Information and Influencing Behavior Involving Carbon Dioxide Emissions
Red Light Holland
Core One Labs’ Akome Biotech Protects New AKO003 Ketamine-Based Breakthrough Drug Formulation For Depression Treatment
Core One Labs Inc.
NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity
NeonMind Biosciences Inc.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.